fresh
A company interested in radiotherapies, part of the 15 billion M&A and deal making in the last few years. observed
No person- or entity-level identity check is on record for this company. A name match is not one.
The inclusion bar: two or more independent sourced evidence families. This profile is reachable but not in the ranked index. It is a statement about how much evidence we hold, and about nothing else.
We have not established fit. That is not a soft no and not a soft yes — it is unknown, and it is never counted as a qualified prospect.
↗ Strongest signal: funding_magnitude (13% of the score).
↓ Scored on 1 of 4 components — funding_recency, adoption, developer had no computable metric.
No single number decides. Layers can disagree — that's the point. New to this? →
I said hey you know I think we can fill a very big chunk of your strategic hole if if if we can work together
they were working through their strategy about what do we want to do in digital do we want to be doing digital therapeutics as point solutions inside each as a companion to every drug that we have or do we want to have a broader digital platform
the CEO of Bayer pharmaceutical used to be the CEO of Santa Fe the French pharmaceutical company diabetes Sanofi diabetes unit and so I'd been doing work with Santa Fe for mint for several years now and their teams and everything and so that CEO and I developed a personal relationship
and then bear you know came in on the on the series be recently you know with a huge word of confidence for us so that was that was a so so having investors that that are willing to either ride along with the journey you know you've been fabulous some of the other folks and then and then have that validated by you know one of the largest health care companies in the world it's been it's been humbling
VentureSignalScore 34.8/100 for bayer, composed from 1 of 4 components (emerging formula), discounted ×0.79 for 30% signal coverage
| Component | Weight | Normalized | Contribution |
|---|---|---|---|
| funding_magnitude | 0.3 | 0.4408 |
funding.round.amount_usd 2020-01-28 artifact ↗ An evidence gap, not proof of falsity: Form D is not always required (foreign offerings, certain exemptions) or may not be filed yet.
A first sale, a filing, an amendment and a public announcement are not the same event, and one date may not stand in for another. Where the latest financing date cannot be established from what we hold, this says unknown rather than substituting a date we do have.
No reported round and no SEC filing on record — no financing date is established.
| Attribute | Value | Kind | Source | Observed | State | Conf. |
|---|---|---|---|---|---|---|
common_name | Bayer | observed | artifact ↗ | 2026-07-18 | normalized | 0.60 |
community.hn.max_points | 486 | observed | artifact ↗ | 2026-07-18 | superseded | 0.20 |
community.hn.max_points | 0 | observed | artifact ↗ | 2026-10-08 | normalized | 0.20 |
community.hn.mentions | 50 | observed | artifact ↗ | 2026-07-18 | superseded | 0.20 |
community.hn.mentions | 0 | observed | artifact ↗ | 2026-10-08 | normalized | 0.20 |
community.hn.rumors | [] | observed | artifact ↗ | 2026-07-18 | normalized | 0.20 |
community.hn.top_story | {"url": "https://news.ycombinator.com/item?id=40102779", "title": "Bayer is getting rid of bosses and asking staff to ‘self-organize’", "points": 486, "created_at": "2024-04-21"} | observed | artifact ↗ | 2026-07-18 | superseded | 0.20 |
community.hn.top_story | {"url": "https://news.ycombinator.com/item?id=40102779", "title": "Bayer is getting rid of bosses and asking staff to ‘self-organize’", "points": 486, "created_at": "2024-04-21"} | observed | artifact ↗ | 2026-08-16 | superseded | 0.20 |
community.hn.top_story | {"url": "https://news.ycombinator.com/item?id=40102779", "title": "Bayer is getting rid of bosses and asking staff to ‘self-organize’", "points": 486, "created_at": "2024-04-21"} | observed | artifact ↗ | 2024-04-21 | superseded | 0.20 |
community.hn.top_story | {"url": "https://news.ycombinator.com/item?id=40102779", "title": "Bayer is getting rid of bosses and asking staff to ‘self-organize’", "points": 486, "created_at": "2024-04-21"} | observed | artifact ↗ | 2024-04-21 | superseded | 0.20 |
community.hn.top_story | {"url": "https://news.ycombinator.com/item?id=40102779", "title": "Bayer is getting rid of bosses and asking staff to ‘self-organize’", "points": 486, "created_at": "2024-04-21"} | observed | artifact ↗ | 2024-04-21 | superseded | 0.20 |
community.hn.top_story | {"url": "https://news.ycombinator.com/item?id=40102779", "title": "Bayer is getting rid of bosses and asking staff to ‘self-organize’", "points": 486, "created_at": "2024-04-21"} | observed | artifact ↗ | 2024-04-21 | superseded | 0.20 |
community.hn.top_story | {"url": "https://news.ycombinator.com/item?id=40102779", "title": "Bayer is getting rid of bosses and asking staff to ‘self-organize’", "points": 486, "created_at": "2024-04-21"} | observed | artifact ↗ | 2024-04-21 | superseded | 0.20 |
community.hn.top_story | {"url": "https://news.ycombinator.com/item?id=40102779", "title": "Bayer is getting rid of bosses and asking staff to ‘self-organize’", "points": 486, "created_at": "2024-04-21"} | observed | artifact ↗ | 2024-04-21 | superseded | 0.20 |
community.hn.top_story | {} | observed | artifact ↗ | 2026-10-08 | normalized | 0.20 |
description | A company interested in radiotherapies, part of the 15 billion M&A and deal making in the last few years. | observed | artifact ↗ | 2026-07-18 | normalized | 0.60 |
funding.round.amount_usd | 40000000 | observed | artifact ↗ | 2020-01-28 | normalized | 0.50 |
funding.round.stage | series_b | observed | artifact ↗ | 2020-01-28 | normalized | 0.50 |
index.ai_tie | NOT_AI | observed | classify | 2026-07-25 | derived | 0.60 |
metric.venture.funding_amount_usd | 40000000 | derived | calc | 2026-09-18 | derived | 0.50 |
platform.index_excluded | true | derived | calc | 2026-09-28 | normalized | 0.99 |
score.venture_signal | 34.8 | derived | calc | 2026-09-18 | derived | 0.26 |
sector | emerging | derived | calc | 2026-08-08 | normalized | 0.50 |
signal.commentary | {"context": null, "run_ref": "01M2TVZN6R34X2TEWQPY7F3TB8", "signals": [{"quote": "and then bear you know came in on the on the series be recently you know with a huge word of confidence for us so that | observed | artifact ↗ | 2020-01-28 | promoted | 0.50 |
signal.commentary | {"context": null, "run_ref": "01M2TVZN6R34X2TEWQPY7F3TB8", "signals": [{"quote": "the CEO of Bayer pharmaceutical used to be the CEO of Santa Fe the French pharmaceutical company diabetes Sanofi diabe | observed | artifact ↗ | 2020-01-28 | promoted | 0.50 |
signal.commentary | {"context": null, "run_ref": "01M2TVZN6R34X2TEWQPY7F3TB8", "signals": [{"quote": "they were working through their strategy about what do we want to do in digital do we want to be doing digital therape | observed | artifact ↗ | 2020-01-28 | promoted | 0.50 |
signal.commentary | {"context": null, "run_ref": "01M2TVZN6R34X2TEWQPY7F3TB8", "signals": [{"quote": "I said hey you know I think we can fill a very big chunk of your strategic hole if if if we can work together", "stanc | observed | artifact ↗ | 2020-01-28 | promoted | 0.50 |
source.document.reference | {"kind": "video", "title": "All-In — Best Ideas Pitch Competition — bayer", "source_id": "01KXRPBDZ2FE2BHN1CAREA46SJ-m-107eaa270bb4d714", "extract_ref": "artifact:sha256:d620f51be2974e329f6969a697d1c4 | observed | artifact ↗ | 2026-07-18 | normalized | 0.95 |
source.document.reference | {"kind": "video", "title": "E1022 One Drop CEO Jeff Dachis on helping people w/diabetes, partnering with Bayer, actionable data — bayer", "source_id": "01KXRSPPSCWQ73WP1TRZ64Z7XT-m-107eaa270bb4d714", | observed | artifact ↗ | 2026-09-18 | normalized | 0.95 |